{"id":8370,"date":"2021-05-05T00:28:27","date_gmt":"2021-05-04T22:28:27","guid":{"rendered":"http:\/\/iguanasmoke.com\/?p=8370"},"modified":"2026-08-27T13:03:33","modified_gmt":"2026-08-27T11:03:33","slug":"ce-que-dit-loms-sur-le-cbd","status":"publish","type":"post","link":"https:\/\/iguanasmoke.com\/fr\/que-dice-la-oms-sobre-el-cbd\/","title":{"rendered":"Que dit l'OMS \u00e0 propos du CBD ?"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><strong>Derni\u00e8re mise \u00e0 jour :<\/strong> 27 ao\u00fbt 2026 \u00b7 <strong>Auteur :<\/strong> Rafa Mendiri, co-fondateur d'Iguana Smoke<\/p>\n\n\n\n<h2 id=\"h-respuesta-directa\" class=\"wp-block-heading\">R\u00e9ponse directe<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Que dit l'OMS sur le CBD ? En synth\u00e8se, selon le rapport d'examen critique sur le cannabidiol (CBD) publi\u00e9 par le Comit\u00e9 d'experts de la pharmacod\u00e9pendance de l'Organisation mondiale de la sant\u00e9 (OMS) en 2018, il n'existe aucune preuve que le CBD g\u00e9n\u00e8re une d\u00e9pendance, un abus ou des probl\u00e8mes de sant\u00e9 publique, et le comit\u00e9 a recommand\u00e9 que les pr\u00e9parations de CBD r\u00e9pondant \u00e0 la d\u00e9finition \u00e9tablie ne soient pas soumises \u00e0 un contr\u00f4le international en tant que stup\u00e9fiants<a href=\"https:\/\/www.who.int\/publications\/m\/item\/cannabidiol\" target=\"_blank\" rel=\"noopener noreferrer\">OMS, 2018<\/a>). Cela ne signifie pas pour autant que le CBD \u00e9chappe \u00e0 toute r\u00e9gulation : tant l'Union europ\u00e9enne que l'Espagne maintiennent des cadres juridiques sp\u00e9cifiques qu'il convient de conna\u00eetre avant d'acheter ou de vendre.<\/p>\n\n\n\n<h2 id=\"h-que-dice-la-oms-sobre-el-cbd\" class=\"wp-block-heading\">Que dit l'OMS \u00e0 propos du CBD ?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Le Comit\u00e9 d'experts de la pharmacod\u00e9pendance (CEPD) de l'OMS a \u00e9valu\u00e9 le CBD s\u00e9par\u00e9ment des autres cannabino\u00efdes tels que le THC, pr\u00e9cis\u00e9ment parce qu'il ne partage pas son profil psychoactif. Son rapport de 2018 d\u00e9crit un profil de s\u00e9curit\u00e9 et de tol\u00e9rabilit\u00e9 favorable, sans aucun signe de potentiel d'abus ou de d\u00e9pendance associ\u00e9 au CBD pur (<a href=\"https:\/\/www.who.int\/publications\/m\/item\/cannabidiol\" target=\"_blank\" rel=\"noopener noreferrer\">OMS, Rapport d'examen critique du cannabidiol, 2018<\/a>).<\/p>\n\n\n\n<h2 id=\"h-como-regula-la-union-europea-el-cbd\" class=\"wp-block-heading\">Comment l'Union europ\u00e9enne r\u00e9glemente-t-elle le CBD ?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">La Commission europ\u00e9enne classe les extraits de Cannabis sativa L. et le CBD synth\u00e9tique comme \u00ab novel food \u00bb (nouvel aliment) dans son <a href=\"https:\/\/food.ec.europa.eu\/food-safety\/novel-food\/novel-food-status-catalogue_en\" target=\"_blank\" rel=\"noopener noreferrer\">Catalogue des statuts des nouveaux aliments<\/a>, ce qui signifie que sa commercialisation dans les denr\u00e9es alimentaires ou les compl\u00e9ments alimentaires n\u00e9cessite une autorisation de s\u00e9curit\u00e9 pr\u00e9alable sp\u00e9cifique. En parall\u00e8le, l'Autorit\u00e9 europ\u00e9enne de s\u00e9curit\u00e9 des aliments (EFSA) a \u00e9tabli un <a href=\"https:\/\/www.efsa.europa.eu\/en\/news\/provisional-safe-level-cannabidiol-novel-food\" target=\"_blank\" rel=\"noopener noreferrer\">niveau d'apport provisoire consid\u00e9r\u00e9 comme s\u00fbr pour les adultes<\/a>, soulignant \u00e9galement que des lacunes dans l'information scientifique persistent et continuent d'\u00eatre examin\u00e9es.<\/p>\n\n\n\n<h2 id=\"h-cual-es-la-situacion-legal-del-cbd-en-espana\" class=\"wp-block-heading\">Quelle est la situation l\u00e9gale du CBD en Espagne ?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">En Espagne, le cadre des stup\u00e9fiants et des psychotropes est g\u00e9r\u00e9 par <a href=\"https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/estupefacientes-y-psicotropos\/\" target=\"_blank\" rel=\"noopener noreferrer\">Agence espagnole des m\u00e9dicaments et des produits de sant\u00e9 (AEMPS)<\/a>, qui r\u00e9glemente la culture, la production et l'utilisation du cannabis et de ses d\u00e9riv\u00e9s. Actuellement, le seul m\u00e9dicament \u00e0 base de CBD autoris\u00e9 en Espagne est l'Epidyolex\u00ae, indiqu\u00e9 comme traitement adjuvant dans le syndrome de Lennox-Gastaut et le syndrome de Dravet, selon le <a href=\"https:\/\/www.aemps.gob.es\/informa\/informes-de-posicionamiento-terapeutico\/informe-de-posicionamiento-terapeutico-de-cannabidiol-epidyolex-en-el-tratamiento-coadyuvante-del-sindrome-de-lennox-gastaut-y-sindrome-de-dravet\/\" target=\"_blank\" rel=\"noopener noreferrer\">Avis de S-P-T<\/a> publi\u00e9 par l'AEMPS elle-m\u00eame. Cet usage m\u00e9dical approuv\u00e9 est distinct des produits de CBD de consommation courante, dont la commercialisation est soumise aux limites de THC et \u00e0 la r\u00e9glementation sur les \u00ab nouveaux aliments \u00bb mentionn\u00e9e ci-dessus. Si vous souhaitez approfondir la question des limites de THC autoris\u00e9es pour qu'un produit soit consid\u00e9r\u00e9 comme du CBD l\u00e9gal, vous pouvez consulter notre guide sur <a href=\"https:\/\/iguanasmoke.com\/fr\/le-cbd-est-il-legal-en-espagne-et-en-europe-points-cles-sur-la-limite-legale-de-thc\/\">si le CBD est l\u00e9gal en Espagne et en Europe<\/a>.<\/p>\n\n\n\n<h2 id=\"h-preguntas-frecuentes\" class=\"wp-block-heading\">Questions fr\u00e9quemment pos\u00e9es<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1787828469927\"><strong class=\"schema-faq-question\">L'OMS consid\u00e8re-t-elle le CBD comme une substance contr\u00f4l\u00e9e ?<\/strong> <p class=\"schema-faq-answer\">Non. Son rapport de 2018 a recommand\u00e9 que le CBD, dans les conditions que le rapport lui-m\u00eame d\u00e9finit, ne soit pas inclus dans les listes de contr\u00f4le international des stup\u00e9fiants.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1787828494917\"><strong class=\"schema-faq-question\">Puis-je vendre du CBD dans des aliments ou des compl\u00e9ments alimentaires dans l'UE sans formalit\u00e9s ?<\/strong> <p class=\"schema-faq-answer\">Non. La Commission europ\u00e9enne le classe comme nouvel aliment, ce qui exige une autorisation de s\u00e9curit\u00e9 pr\u00e9alable avant sa vente comme aliment ou compl\u00e9ment.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1787828521865\"><strong class=\"schema-faq-question\">Existe-t-il un m\u00e9dicament \u00e0 base de CBD approuv\u00e9 en Espagne ?<\/strong> <p class=\"schema-faq-answer\">Oui, l'Epidyolex\u00ae, uniquement pour deux syndromes sp\u00e9cifiques d'\u00e9pilepsie infantile, selon le rapport de positionnement th\u00e9rapeutique publi\u00e9 par l'AEMPS. Cela n'\u00e9quivaut pas \u00e0 une approbation g\u00e9n\u00e9rale de l'usage m\u00e9dical du CBD.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1787828547917\"><strong class=\"schema-faq-question\">Quelle autorit\u00e9 r\u00e9glemente le CBD en Espagne ?<\/strong> <p class=\"schema-faq-answer\">L'AEMPS, dans le cadre des stup\u00e9fiants et des psychotropes.<\/p> <\/div> <\/div>\n\n\n\n<h2 id=\"h-fuentes-oficiales\" class=\"wp-block-heading\">Sources officielles<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Organisation mondiale de la sant\u00e9 (OMS) \u2014 <a href=\"https:\/\/www.who.int\/publications\/m\/item\/cannabidiol\" target=\"_blank\" rel=\"noopener noreferrer\">Rapport d'examen critique du cannabidiol (CBD), 2018<\/a><\/li>\n\n\n\n<li>Commission europ\u00e9enne \u2014 <a href=\"https:\/\/food.ec.europa.eu\/food-safety\/novel-food\/novel-food-status-catalogue_en\" target=\"_blank\" rel=\"noopener noreferrer\">Catalogue des nouveaux aliments<\/a><\/li>\n\n\n\n<li>EFSA \u2014 <a href=\"https:\/\/www.efsa.europa.eu\/en\/news\/provisional-safe-level-cannabidiol-novel-food\" target=\"_blank\" rel=\"noopener noreferrer\">Niveau de s\u00e9curit\u00e9 provisoire pour le cannabidiol en tant que nouvel aliment<\/a><\/li>\n\n\n\n<li>AEMPS \u2014 <a href=\"https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/estupefacientes-y-psicotropos\/\" target=\"_blank\" rel=\"noopener noreferrer\">Stup\u00e9fiants et psychotropes<\/a><\/li>\n\n\n\n<li>AEMPS \u2014 <a href=\"https:\/\/www.aemps.gob.es\/informa\/informes-de-posicionamiento-terapeutico\/informe-de-posicionamiento-terapeutico-de-cannabidiol-epidyolex-en-el-tratamiento-coadyuvante-del-sindrome-de-lennox-gastaut-y-sindrome-de-dravet\/\" target=\"_blank\" rel=\"noopener noreferrer\">Rapport de positionnement th\u00e9rapeutique du cannabidiol (Epidyolex\u00ae)<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Cet article se base exclusivement sur des sources officielles (OMS, Commission europ\u00e9enne, EFSA et AEMPS) et est destin\u00e9 \u00e0 des fins \u00e9ducatives g\u00e9n\u00e9rales. Il ne remplace pas un avis m\u00e9dical, juridique ou professionnel. Consultez toujours un professionnel qualifi\u00e9.<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Selon le rapport de l'OMS (2018), le CBD ne cr\u00e9e pas de d\u00e9pendance et ne repr\u00e9sente pas un risque pour la sant\u00e9 publique. D\u00e9couvrez comment il est r\u00e9glement\u00e9 par l'Union europ\u00e9enne et l'Espagne, avec des liens vers les sources officielles.<\/p>","protected":false},"author":13027,"featured_media":8915,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[317,318],"tags":[400,822,779,818,819,815,823,604,820,817,821,824,816],"class_list":["post-8370","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cbd","category-informacion-general","tag-beneficios-del-cbd","tag-cbd-analgesico","tag-cbd-ansiedad","tag-cbd-antiinflamatorio","tag-cbd-epilepsia","tag-cbd-no-adictivo","tag-cbd-seguro","tag-efectos-del-cbd","tag-estudios-sobre-el-cbd","tag-informe-oms-cbd","tag-oms-cannabidiol","tag-project-cbd","tag-propiedades-del-cannabidiol"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.5 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>\u00bfQu\u00e9 dice la OMS sobre el CBD? | Iguana Smoke<\/title>\n<meta name=\"description\" content=\"Qu\u00e9 dice la OMS sobre el CBD: no genera dependencia, seg\u00fan su informe de 2018. Conoce c\u00f3mo lo regulan la UE y Espa\u00f1a, con enlaces a las fuentes oficiales.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/iguanasmoke.com\/fr\/ce-que-dit-loms-sur-le-cbd\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00bfQu\u00e9 dice la OMS sobre el CBD?\" \/>\n<meta property=\"og:description\" content=\"Seg\u00fan el informe de la OMS (2018), el CBD no genera dependencia ni supone un riesgo para la salud p\u00fablica. Descubre c\u00f3mo lo regulan la Uni\u00f3n Europea y Espa\u00f1a, con enlaces a las fuentes oficiales.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/iguanasmoke.com\/fr\/ce-que-dit-loms-sur-le-cbd\/\" \/>\n<meta property=\"og:site_name\" content=\"Iguana Smoke\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/iguanasmoke\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-04T22:28:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-27T11:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/iguanasmoke.com\/wp-content\/uploads\/2018\/02\/OMS.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Rafa Mendiri\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rafa Mendiri\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Que dit l'OMS \u00e0 propos du CBD ? | Iguana Smoke","description":"Que dit l'OMS sur le CBD : il ne cr\u00e9e pas de d\u00e9pendance, selon son rapport de 2018. D\u00e9couvrez comment l'UE et l'Espagne le r\u00e9glementent, avec des liens vers les sources officielles.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/iguanasmoke.com\/fr\/ce-que-dit-loms-sur-le-cbd\/","og_locale":"fr_FR","og_type":"article","og_title":"\u00bfQu\u00e9 dice la OMS sobre el CBD?","og_description":"Seg\u00fan el informe de la OMS (2018), el CBD no genera dependencia ni supone un riesgo para la salud p\u00fablica. Descubre c\u00f3mo lo regulan la Uni\u00f3n Europea y Espa\u00f1a, con enlaces a las fuentes oficiales.","og_url":"https:\/\/iguanasmoke.com\/fr\/ce-que-dit-loms-sur-le-cbd\/","og_site_name":"Iguana Smoke","article_publisher":"https:\/\/www.facebook.com\/iguanasmoke","article_published_time":"2021-05-04T22:28:27+00:00","article_modified_time":"2026-08-27T11:03:33+00:00","og_image":[{"width":1500,"height":1000,"url":"https:\/\/iguanasmoke.com\/wp-content\/uploads\/2018\/02\/OMS.png","type":"image\/png"}],"author":"Rafa Mendiri","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Rafa Mendiri","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#article","isPartOf":{"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/"},"author":{"name":"Rafa Mendiri","@id":"https:\/\/iguanasmoke.com\/#\/schema\/person\/e55d67e1c505164d09ce1ce25fa3cae0"},"headline":"\u00bfQu\u00e9 dice la OMS sobre el CBD?","datePublished":"2021-05-04T22:28:27+00:00","dateModified":"2026-08-27T11:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/"},"wordCount":681,"commentCount":0,"publisher":{"@id":"https:\/\/iguanasmoke.com\/#organization"},"image":{"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#primaryimage"},"thumbnailUrl":"https:\/\/iguanasmoke.com\/wp-content\/uploads\/2018\/02\/OMS.png","keywords":["beneficios del cbd","CBD analg\u00e9sico","CBD ansiedad","CBD antiinflamatorio","CBD epilepsia","CBD no adictivo","CBD seguro","efectos del CBD","estudios sobre el CBD","informe OMS CBD","OMS cannabidiol","Project CBD","propiedades del cannabidiol"],"articleSection":["CBD","Informaci\u00f3n General"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#respond"]}]},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/","url":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/","name":"Que dit l'OMS \u00e0 propos du CBD ? | Iguana Smoke","isPartOf":{"@id":"https:\/\/iguanasmoke.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#primaryimage"},"image":{"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#primaryimage"},"thumbnailUrl":"https:\/\/iguanasmoke.com\/wp-content\/uploads\/2018\/02\/OMS.png","datePublished":"2021-05-04T22:28:27+00:00","dateModified":"2026-08-27T11:03:33+00:00","description":"Que dit l'OMS sur le CBD : il ne cr\u00e9e pas de d\u00e9pendance, selon son rapport de 2018. D\u00e9couvrez comment l'UE et l'Espagne le r\u00e9glementent, avec des liens vers les sources officielles.","breadcrumb":{"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#breadcrumb"},"mainEntity":[{"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828469927"},{"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828494917"},{"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828521865"},{"@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828547917"}],"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#primaryimage","url":"https:\/\/iguanasmoke.com\/wp-content\/uploads\/2018\/02\/OMS.png","contentUrl":"https:\/\/iguanasmoke.com\/wp-content\/uploads\/2018\/02\/OMS.png","width":1500,"height":1000,"caption":"Logo de la Organizaci\u00f3n Mundial de la Salud (OMS), autora del informe sobre el CBD"},{"@type":"BreadcrumbList","@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"home","item":"https:\/\/iguanasmoke.com\/"},{"@type":"ListItem","position":2,"name":"\u00bfQu\u00e9 dice la OMS sobre el CBD?"}]},{"@type":"WebSite","@id":"https:\/\/iguanasmoke.com\/#website","url":"https:\/\/iguanasmoke.com\/","name":"Fum\u00e9e d'iguane","description":"Acheter du CBD en ligne au meilleur prix","publisher":{"@id":"https:\/\/iguanasmoke.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/iguanasmoke.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/iguanasmoke.com\/#organization","name":"Fum\u00e9e d'iguane","url":"https:\/\/iguanasmoke.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/iguanasmoke.com\/#\/schema\/logo\/image\/","url":"https:\/\/iguanasmoke.com\/wp-content\/uploads\/2025\/01\/logoiguana-favi-1.png","contentUrl":"https:\/\/iguanasmoke.com\/wp-content\/uploads\/2025\/01\/logoiguana-favi-1.png","width":512,"height":512,"caption":"Iguana Smoke"},"image":{"@id":"https:\/\/iguanasmoke.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/iguanasmoke","https:\/\/www.instagram.com\/iguanasmoke\/"]},{"@type":"Person","@id":"https:\/\/iguanasmoke.com\/#\/schema\/person\/e55d67e1c505164d09ce1ce25fa3cae0","name":"Rafa Mendiri","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/34618d0527247ce8fc4751685a2fa436b6816922830ffd463ace946e2c3f2b05?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34618d0527247ce8fc4751685a2fa436b6816922830ffd463ace946e2c3f2b05?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34618d0527247ce8fc4751685a2fa436b6816922830ffd463ace946e2c3f2b05?s=96&d=mm&r=g","caption":"Rafa Mendiri"},"description":"Rafa Mendiri est co-fondateur d'Iguana Smoke et sp\u00e9cialiste en marketing et communication. Il s'attache \u00e0 diffuser des informations claires et v\u00e9rifi\u00e9es sur le CBD et les cannabino\u00efdes l\u00e9gaux aupr\u00e8s du public hispanophone, en s'appuyant sur des sources officielles telles que les rapports de l'OMS et la r\u00e9glementation en vigueur en Espagne et dans l'Union europ\u00e9enne.","sameAs":["https:\/\/iguanasmoke.com"],"url":"https:\/\/iguanasmoke.com\/fr\/author\/rafa-mendiri\/"},{"@type":"Question","@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828469927","position":1,"url":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828469927","name":"L'OMS consid\u00e8re-t-elle le CBD comme une substance contr\u00f4l\u00e9e ?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"No. Su informe de 2018 recomend\u00f3 que el CBD, en las condiciones que el propio informe define, no se incluya en las listas de fiscalizaci\u00f3n internacional de estupefacientes.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828494917","position":2,"url":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828494917","name":"Puis-je vendre du CBD dans des aliments ou des compl\u00e9ments alimentaires dans l'UE sans formalit\u00e9s ?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"No. La Comisi\u00f3n Europea lo clasifica como alimento nuevo, lo que exige una autorizaci\u00f3n de seguridad previa antes de su venta como alimento o complemento.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828521865","position":3,"url":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828521865","name":"Existe-t-il un m\u00e9dicament \u00e0 base de CBD approuv\u00e9 en Espagne ?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"S\u00ed, Epidyolex\u00ae, \u00fanicamente para dos s\u00edndromes espec\u00edficos de epilepsia infantil, seg\u00fan el Informe de Posicionamiento Terap\u00e9utico publicado por la AEMPS. Esto no equivale a una aprobaci\u00f3n general de uso m\u00e9dico del CBD.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828547917","position":4,"url":"https:\/\/iguanasmoke.com\/que-dice-la-oms-sobre-el-cbd\/#faq-question-1787828547917","name":"Quelle autorit\u00e9 r\u00e9glemente le CBD en Espagne ?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"La AEMPS, dentro del marco de estupefacientes y psicotr\u00f3picos.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/posts\/8370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/users\/13027"}],"replies":[{"embeddable":true,"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/comments?post=8370"}],"version-history":[{"count":9,"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/posts\/8370\/revisions"}],"predecessor-version":[{"id":95794,"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/posts\/8370\/revisions\/95794"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/media\/8915"}],"wp:attachment":[{"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/media?parent=8370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/categories?post=8370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iguanasmoke.com\/fr\/wp-json\/wp\/v2\/tags?post=8370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}